Insmed, Inc. (INSM)
NASDAQ · Manufacturing · Pharmaceutical preparations
INSM price, last 12 months
Key stats
- Previous close
- $119.80
- Open
- $119.50
- Day range
- $118.00 – $149.07
- 52-week range
- $90.39 – $212.75
- Volume
- 14.4M
- Avg volume (20 days)
- 4.3M
- Market cap
- $26.6B
Performance
Technicals and fundamentals
About Insmed, Inc.
Insmed Inc is a biopharmaceutical company. Its commercial portfolio and clinical pipeline are organized around three therapeutic areas: Respiratory, Immunology and Inflammation, and Neuro and Other Rare. The company's two commercial products, Arikayce and Brinsupri, are both part of the Respiratory therapeutic area. The firm's clinical-stage programs are TPIP, INS1148, brensocatib, and INS1201, focusing on different therapeutic areas. Additionally, Insmed's pre-clinical research programs encompass various technologies and modalities, including gene therapy, AI-driven protein engineering, protein manufacturing, RNA end-joining, and synthetic rescue. Geographically, the company generates maximum revenue from the United States from the sale of its commercial products.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $26.6B